Phosphoric Acid — predicted protein targets

Known targets — ChEMBL curated mechanism

ADRA1A ADRA1B ADRA1D ADRB1 ADRB2 ADRB3 CYP11B1 DPP4 FGFR1 FGFR2 FGFR3 FGFR4 HRH1 JAK1 JAK2 JAK3 KCNA1 KCNA10 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 KCNB1 KCNB2 KCNC1 KCNC2 KCNC3 KCNC4 KCND1 KCND2 KCND3 KCNF1 KCNG1 KCNG2 KCNG3 KCNG4 KCNH1 KCNH2 KCNH3 KCNH4 KCNH5 KCNH6 KCNH7 KCNH8 KCNQ1 KCNQ2 KCNQ3 KCNQ4 KCNQ5 KCNS1 KCNS2 KCNS3 KCNV1 KCNV2 KDR KIT NA OPRD1 OPRK1 OPRM1 P PDGFRB PIK3CD SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SMO TYK2 pol rplA rplB rplC rplD rplE rplF rplJ rplK rplL rplM rplN rplO rplP rplQ rplR rplS rplT rplU rplV rplW rplX rplY rpmA rpmB rpmC rpmD rpmE rpmF rpmG rpmH rpmI rpmJ rpsA rpsB rpsC rpsD rpsE rpsF rpsG rpsH rpsI rpsJ rpsK rpsL rpsM rpsN rpsO rpsP rpsQ rpsR rpsS rpsT rpsU ykgM ykgO

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

	gene	UniProt	supporting neighbours	confidence
▸	CA2	P00918	3/20	0.50

▸	CA1	P00915	1/20	0.50

▸	CA9	Q16790	1/20	0.50

▸	BLM	P54132	2/20	0.41

▸	TDP1	Q9NUW8	2/20	0.41

▸	LMNA	P02545	2/20	0.41

▸	MEN1	O00255	1/20	0.41

▸	HPGD	P15428	1/20	0.41

▸	TSHR	P16473	1/20	0.41

▸	KMT2A	Q03164	1/20	0.41

▸	CA4	P22748	2/20	0.39

▸	SLC34A1	Q06495	1/20	0.36

▸	MMP2	P08253	2/20	0.33

▸	KDM4E	B2RXH2	1/20	0.33

▸	THRB	P10828	1/20	0.33

▸	MAPK1	P28482	1/20	0.33

▸	HSD17B10	Q99714	1/20	0.33

▸	PEPD	P12955	1/20	0.33

▸	FDPS	P14324	1/20	0.33

▸	MMP3	P08254	1/20	0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Phosphoric Acid SCHEMBL29012844	1.00	CA2 (0.50)	CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL18259562	0.95	CA2 (0.46)	CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL7775151	0.95	CA2 (0.46)	CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL3880757	0.95	CA2 (0.56)	CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL8058372	0.95	CA2 (0.56)	CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL23721810	0.95	CA2 (0.56)	CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL9678210	0.95	CA2 (0.56)	CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL981031	0.95	—	—
Phosphoric Acid SCHEMBL28217385	0.91	CA2 (0.42)	CA2CA1CA9BLMTDP1
Phosphoric Acid SCHEMBL20718883	0.90	—	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-10081588-B2	Production of butyl acetate from ethanol	RESCURVE, LLC (US)	2018-09-25	—	—	US	claimed
US-20160297737-A1	Production of Butyl Acetate from Ethanol	VIRIDIS CHEMICAL, LLC	2016-10-13	—	—	US	claimed
EP-2958881-A1	PRODUCTION OF HIGHER ALCOHOLS	Greenyug, LLC (US)	2015-12-30	—	—	EP	claimed
WO-2015085002-A1	PRODUCTION OF BUTYL ACETATE FROM ETHANOL	GREENYUG, LLC (US)	2015-06-11	—	—	WO	claimed
US-9018427-B2	Production of higher alcohols	GREENYUG, LLC (US)	2015-04-28	—	—	US	claimed
WO-2014130465-A1	PRODUCTION OF HIGHER ALCOHOLS	GREENYUG, LLC (US)	2014-08-28	—	—	WO	claimed
US-20140235901-A1	Production of Higher Alcohols	GREENYUG, LLC (US)	2014-08-21	—	—	US	claimed
US-10898418-B2	Cosmetic composition	INTERCOS S.P.A. (IT)	2021-01-26	—	—	US	disclosed
CN-106470664-B	Cosmetic composition	莹特丽股份公司	2020-03-31	—	—	CN	disclosed
EP-3166576-B1	COSMETIC COMPOSITION	INTERCOS ITALIANA (IT)	2019-02-20	—	—	EP	disclosed
US-10081588-B2	Production of butyl acetate from ethanol	RESCURVE, LLC (US)	2018-09-25	—	—	US	disclosed
US-20170246239-A1	ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE	Shah Shetal Amit (US)	2017-08-31	—	—	US	disclosed
US-20170239317-A1	ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE	Shah Shetal Amit (US)	2017-08-24	—	—	US	disclosed
US-20050238611-A1	Cosmetic compositions and their use	INTERCOS S.P.A. (IT)	2005-10-27	—	—	US	disclosed
EP-1588686-A1	Cosmetic compositions and their use	Intercos S.p.A. (IT)	2005-10-26	—	—	EP	disclosed
US-20040191201-A1	Coated cosmetic powder	INTERCOS S.P.A (IT)	2004-09-30	—	—	US	disclosed
US-20040191197-A1	Cosmetic composition containing polyisoprene	INTERCOS S.P.A. (IT)	2004-09-30	—	—	US	disclosed
EP-1454611-A2	Coated cosmetic powder	Intercos S.p.A. (IT)	2004-09-08	—	—	EP	disclosed
EP-1454621-A2	Cosmetic composition containing polyisoprene	Intercos S.p.A. (IT)	2004-09-08	—	—	EP	disclosed
US-4347285-A	AN ALKALI METAL SILICATE, A COREACTANT METAL SALT AND AN ELASTOMERC LATEX	H. B. FULLER COMPANY (US)	1982-08-31	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20170239317-A1	ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE	BCL2L10, MMP11, MMP10	CA2 2683/4885CA1 2679/4885CA9 1028/4885
US-20170246239-A1	ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE	BCL2L10, MMP11, MMP10	CA2 2683/4885CA1 2679/4885CA9 1028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.